소변 검사 시장 - 세계 산업 규모, 점유율, 동향, 경쟁, 기회, 예측 : 제품 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Urinalysis Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product, By Test Type, By Application, By End user, By Region and Competition, 2020-2030F
상품코드:1770863
리서치사:TechSci Research
발행일:2025년 07월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
소변 검사 세계 시장은 2024년에는 43억 9,000만 달러로 평가되었으며, 2030년에는 68억 4,000만 달러에 달하고, CAGR 7.67%로 성장할 것으로 예측됩니다.
이러한 성장은 당뇨병, 신장질환 등 만성질환의 유병률 증가가 주요 요인으로 작용하고 있습니다. 소변 검사는 소변의 물리적, 화학적, 현미경적 특성을 검사하는 진단법으로 요로감염증, 신장질환, 당뇨병 등 다양한 건강상태를 감지하고 모니터링하는 진단법입니다. 비침습적이고 유익한 검사법으로 요검사는 조기 진단 및 질병 관리 분야에서 각광받고 있습니다. 또한, 비뇨기 및 신장 건강에 대한 대중의 인식이 높아지면서 정부 지원 및 헬스케어 투자 증가와 함께 선진국과 신흥국 시장 모두에서 접근성이 높아져 수요가 증가하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
43억 9,000만 달러
시장 규모 : 2030년
68억 4,000만 달러
CAGR : 2025-2030년
7.67%
급성장 부문
기기
최대 시장
북미
시장 촉진요인
만성질환 증가
주요 시장 과제
규제 준수 및 품질 관리
주요 시장 동향
POC(Point-of-Care) 검사로의 전환
목차
제1장 제품별 개요
시장 정의
시장 범위
대상이 되는 시장.
조사 대상 연도
주요 시장 세분화
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 소변 검사 시장 전망.
시장 규모 및 예측
금액별
시장 점유율과 예측
제품별(소모품·기구)
검사 종류별(임신·불임 검사, 소변 생화학 검사, 소변 침전물 검사)
용도별(질병 스크리닝 및 임신·불임 치료)
최종사용자별(진단 연구소, 병원·진료소, 재택 케어 시설, 조사 연구소·연구기관)
기업별(2024)
지역별
시장 맵
제6장 아시아태평양의 소변 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국.
인도.
한국
일본
호주
제7장 유럽의 소변 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 북미의 소변 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제9장 남미의 소변 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 소변 검사 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
인수합병
제품 개발별
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협/서비스
제14장 소변 검사 시장 : SWOT 분석
제15장 경쟁 구도
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott Laboratories
Cardinal Health Inc.
Danaher Corporation
Sysmex Corporation
Quidel Corporation
Becton, Dickinson & Company
Bio-Rad Laboratories Inc.
EKF Diagnostics Holdings plc
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Urinalysis Market was valued at USD 4.39 billion in 2024 and is projected to reach USD 6.84 billion by 2030, growing at a CAGR of 7.67%. This growth is largely driven by the increasing prevalence of chronic diseases such as diabetes and kidney disorders. Urinalysis is a diagnostic method that examines the physical, chemical, and microscopic properties of urine to detect and monitor a range of health conditions, including urinary tract infections, kidney disease, and diabetes. As a non-invasive and informative testing approach, urinalysis is gaining prominence in early diagnosis and disease management. Additionally, rising public awareness about urinary and kidney health, combined with increased government support and healthcare investment, is enhancing accessibility and fueling demand across both developed and developing markets.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 4.39 Billion
Market Size 2030
USD 6.84 Billion
CAGR 2025-2030
7.67%
Fastest Growing Segment
Instruments
Largest Market
North America
Key Market Drivers
Rising Prevalence of Chronic Diseases
The global rise in chronic conditions-particularly diabetes and chronic kidney disease (CKD)-is a major factor accelerating the growth of the urinalysis market. Urinalysis is a non-invasive, affordable diagnostic tool that plays a critical role in early detection, ongoing monitoring, and treatment planning for these diseases.
According to the World Health Organization (WHO), the global population aged 60 and above is expected to reach 2.1 billion by 2050, significantly increasing the incidence of age-related illnesses such as diabetes and CKD. The International Diabetes Federation noted that 537 million adults were living with diabetes in 2021, with projections indicating this figure will rise to 643 million by 2030. Urinalysis enables detection of biomarkers like glucose, ketones, and protein in urine, making it essential for effective management and timely intervention.
Key Market Challenges
Regulatory Compliance and Quality Control
The urinalysis market faces significant regulatory and quality assurance challenges. Manufacturers must meet stringent requirements imposed by bodies such as the FDA and EMA, which involve comprehensive product testing, documentation, and adherence to Good Manufacturing Practices (GMP). These compliance processes can be time-consuming and financially demanding.
Ensuring consistency in product performance across production batches is crucial, as any variation can compromise diagnostic accuracy. This necessitates rigorous quality control mechanisms and ongoing surveillance. For example, under the FDA's Medical Device Reporting (MDR) regulation, manufacturers are required to report device-related adverse events, ensuring constant monitoring and safety validation. These high standards increase the operational burden, potentially limiting market entry for smaller players and slowing innovation due to the associated costs and complexities.
Key Market Trends
Shift Towards Point-of-Care Testing
A major trend in the urinalysis market is the transition toward point-of-care testing (POCT), driven by the need for rapid diagnostics and decentralized healthcare services. POCT enables immediate testing and results interpretation at the site of care, which enhances clinical responsiveness and patient outcomes.
Urinalysis has emerged as a key area within POCT, thanks to the development of portable, easy-to-use devices that can be deployed in clinics, emergency rooms, and even at home. These devices offer fast analysis of urine parameters like glucose, protein, and leukocytes, facilitating prompt diagnosis and treatment.
Government support has further strengthened this trend. For instance, the Centers for Medicare & Medicaid Services (CMS) in the U.S. have introduced reimbursement policies that encourage POCT use in primary care. During health crises such as the COVID-19 pandemic, regulatory bodies also accelerated the approval of POCT devices to expand diagnostic capacity, underscoring the growing role of POCT in the future of healthcare.
Key Market Players
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
Abbott Laboratories
Cardinal Health Inc.
Danaher Corporation
Sysmex Corporation
Quidel Corporation
Becton, Dickinson & Company
Bio-Rad Laboratories Inc.
EKF Diagnostics Holdings plc
Report Scope:
In this report, the Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Urinalysis Market, By Product:
Consumables
Instruments
Urinalysis Market, By Test Type:
Pregnancy & Fertility Tests
Biochemical Urinalysis
Sediment Urinalysis
Urinalysis Market, By Application:
Disease Screening
Pregnancy & Fertility
Urinalysis Market, By End User:
Diagnostic Laboratories
Hospitals & Clinics
Home Care Settings
Research Laboratories & Institutes
Urinalysis Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Urinalysis Market.
Available Customizations:
Global Urinalysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. By Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Urinalysis Market Outlook.
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Consumables & Instruments)
5.2.2. By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
5.2.3. By Application (Disease Screening and Pregnancy & Fertility)
5.2.4. By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. Asia-Pacific Urinalysis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Test Type
6.2.3. By Application
6.2.4. By End user
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Urinalysis Market Outlook.
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Test Type
6.3.1.2.3. By Application
6.3.1.2.4. By End user
6.3.2. India Urinalysis Market Outlook.
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Test Type
6.3.2.2.3. By Application
6.3.2.2.4. By End user
6.3.3. South Korea Urinalysis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Test Type
6.3.3.2.3. By Application
6.3.3.2.4. By End user
6.3.4. Japan Urinalysis Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Product
6.3.4.2.2. By Test Type
6.3.4.2.3. By Application
6.3.4.2.4. By End user
6.3.5. Australia Urinalysis Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Product
6.3.5.2.2. By Test Type
6.3.5.2.3. By Application
6.3.5.2.4. By End user
7. Europe Urinalysis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Test Type
7.2.3. By Application
7.2.4. By End user
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Urinalysis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Test Type
7.3.1.2.3. By Application
7.3.1.2.4. By End user
7.3.2. Germany Urinalysis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Test Type
7.3.2.2.3. By Application
7.3.2.2.4. By End user
7.3.3. United Kingdom Urinalysis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Test Type
7.3.3.2.3. By Application
7.3.3.2.4. By End user
7.3.4. Italy Urinalysis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Test Type
7.3.4.2.3. By Application
7.3.4.2.4. By End user
7.3.5. Spain Urinalysis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Test Type
7.3.5.2.3. By Application
7.3.5.2.4. By End user
8. North America Urinalysis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Test Type
8.2.3. By Application
8.2.4. By End user
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Urinalysis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Test Type
8.3.1.2.3. By Application
8.3.1.2.4. By End user
8.3.2. Mexico Urinalysis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Test Type
8.3.2.2.3. By Application
8.3.2.2.4. By End user
8.3.3. Canada Urinalysis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Test Type
8.3.3.2.3. By Application
8.3.3.2.4. By End user
9. South America Urinalysis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Test Type
9.2.3. By Application
9.2.4. By End user
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Urinalysis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Test Type
9.3.1.2.3. By Application
9.3.1.2.4. By End user
9.3.2. Argentina Urinalysis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Test Type
9.3.2.2.3. By Application
9.3.2.2.4. By End user
9.3.3. Colombia Urinalysis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Test Type
9.3.3.2.3. By Application
9.3.3.2.4. By End user
10. Middle East and Africa Urinalysis Market Outlook
